A retrospective review of the outcome of plasma exchange and aggressive medical therapy in antibody mediated rejection of renal allografts: A single center experience

Journal of Clinical Apheresis

Volumn 23, Issue 6, 2008, Pages 178-182

  Al Badr, Wisam ^a   Kallogjeri, Dorina ^b   Madaraty, Kamel ^a   Oliver, Dana ^b   Bastani, Bahar ^a   Grossman, Brenda J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Acute humoral rejection; Antibody mediated rejection; Immune mediated rejection; Plasma exchange; Renal transplant

Indexed keywords

ALLOANTIBODY; CREATININE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; CREATINE;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PLASMA VOLUME; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; ALLOTRANSPLANTATION; ARTICLE; BLOOD; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; TIME;

ADOLESCENT; ADULT; CREATINE; FEMALE; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59449090766     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20181     Document Type: Review

References (19)

1. Pascual M, Saidman S, Tolkoff-Rubin N, Williams WW, Mauiyyedi S, Duan JM, Farrell ML, Colvin RB, Cosimi AB, Delmonico FL. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998;66:1460-1464.
2. Soulillou JP, Guyot C, Guimbretiere J, Girard M, Ythier A, Bignon JD, Hourmant M, Guenel J. Plasma exchange in early kidney graft rejection associated with anti-donor antibodies. Nephron 1983;35:158-162.
3. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002;13:779-787.
4. Power D, Nicholls A, Muirhead N, MacLeod AM, Engeset J, Catta GR, Edward N. Plasma exchange in acute renal allograft rejection: is a controlled trial really necessary? Transplantation 1981;32:162-163.
5. Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998;66:800-805.
6. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000;70:887-895.
7. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-723.
8. Al-Aly Z, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding. Transpl Int 2005;18:800-805.
9. Al-Aly Z, Reddivari V, Moiz A, Balasubramanian G, Cortese CM, Salinas-Madrigal L, Bastani B. Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system. Transplant Int 2008;21:268-275.
10. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madrigal L, Salomon DR, Seron D, Sheaff M, Weening JJ. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007;7:518-526.
11. Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN, Smith SR. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003;75:1490-1495.
12. Abraham KA, Brown C, Conlon PJ, Donohoe J, Hickey DP, O'Neill D, Keogan MT, Dorman AM, Walshe J. Plasmapheresis as rescue therapy in accelerated acute humoral rejection. J Clin Apher 2003;18:103-110.
13. Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 2004;77:1399-1405.
14. White NB, Greenstein SM, Cantafio AW, Schechner R, Glicklich D, McDonough P, Pullman J, Mohandas K, Boctor F, Uehlinger J, Tellis V. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004;78:772-774.
15. Ibernon M, Gil-Vernet S, Carrera M, Sero'n D, Moreso F, Bestard O, Cruzado JM, Grinyo' JM. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 2005;37:3743-3745.
16. Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 2005;9:408-415.
17. Smith JW, Weinstein R, Hillyer KL. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:820-822.
18. Cardella CJ, Sutton DM, Falk JA, Katz A, Uldall PR, de Verber GA. Intensive plasma exchange, complement dependent microcytotoxicity and renal transplant rejection. Proc Eur Dial Transplant Assoc 1977;14:328-335.
19. Naik RB, Ashlin R, Wilson C, Smith DS, Lee HA, Slapak M. The role of plasmapheresis in renal transplantation. Clin Nephrol 1979;11:245-250.